INTRODUCTION
It is well known that mutations in DNA can lead to phenotypes that are generally inherited according to Mendelian rules, but which are sometimes inherited differently. The study of nonMendelian transmission has provided several lines of evidence for non-nuclear genetic determinants, such mitochondrial DNA, chloroplast DNA, viruses and plasmids. In yeast, the study of two non-Mendelian inherited phenotypes, [URE3] and [PSI + ], has shown that they were not explained by any of the known nucleic acids, either nuclear or non-nuclear. The yeast elements [PSI + ] and [URE3], discovered by Cox [1, 2] and Lacroute and Aigle [3, 4] , correspond to two distinct phenotypes (the brackets indicate a phenotype in yeast nomenclature, and the capital letters indicate a dominant one). [PSI + ] enhances the suppression of nonsense codon [1, 2, 5] and [URE3] provokes a de-regulation of nitrogen catabolic repression [3, 4] . Wickner and colleagues postulated that these two phenotypes ([URE3] and [PSI + ]) were inherited through a prion mechanism [6] [7] [8] . In mammals, the prion particle is correlated with an infectious agent causing transmissible spongiform encephalopathies [9] . This unconventional agent is presumed to be constituted mainly, if not entirely, by a particular protein, PrP (prion protein ; [10, 11] ), encoded by the genome of the cell [12] . This protein is thought to become infectious by a conformational switch [13] . Once completed, this conformational switch is propagated by interactions between the normal PrP (PrP C ) and the misfolded one (PrP Sc ) [14] . The chain reaction which follows will thus cause the complete change of PrP from normal to pathogen form, which accumulates inside the neurone and finally kills it [15] . Saccharomyces cere isiae is not subjected to an infectious process, but does present similar mechanisms with Sup35p (leading to [PSI + ]) and Ure2p (leading to [URE3]).
We present here the results of a two-hybrid analysis and affinity-binding experiments, using Ure2p as both bait and prey.
MATERIALS AND METHODS

Construction of two-hybrid vectors
The plasmids pAS2 and pACT3 were described previously [16] . pACT3-URE2 was constructed by inserting a BamHI\EcoRI fragment containing the open reading frame (ORF) of the URE2 gene in frame with the activating domain of Gal4p. pAS2-URE2 was constructed by digesting pACT3-URE2 by XhoI and partially by NcoI. The fragment containing the ORF of the URE2 gene was then ligated into pAS2 digested by NcoI and SalI to generate pAS2-URE2. pEX plasmid was constructed as follows : pAS2 was digested by XbaI and EcoRV. The 4.5 kb fragment was then eluted, filled in with T4 DNA polymerase, and religated. The same strategy was used to generate pEX-URE2 from pAS2-URE2.
N-and C-terminal deletions were constructed as follows. pEX-URE2 was digested with appropriate restriction enzymes : ∆C (97-354), PmlI and Bsu36I ; ∆C (152-354), ApaI and Bsu36I ; ∆C (226-354), PflMI and Bsu36I ; ∆N (1-63), NotI; ∆N (1-96), NotI and PmlI ; and ∆N (1-152), NotI and ApaI. The linearized vector was treated with T4 DNA polymerase to form blunt ends and religated with T4 DNA ligase. pAS2-∆URE2 and pACT3-∆URE2 were constructed by gap-repair : the yeast strain Y190 was co-transformed with 1 µg of pAS2 or pACT3 linearized by EcoRI and with 1 µg of pEX-∆URE2 linearized by XmnI. Yeast transformants were selected on medium lacking tryptophan. Finally, the plasmids were recovered in Escherichia coli XL1blue and verified by sequencing.
Construction of in vitro transcription vectors
∆C (97-354)-URE2 : the previously described [16a] N-terminal (6iHis)-influenza haemagglutinin (HA ; YPYPVDYA) epitope-URE2 fusion gene was inserted into the vector pBluescript II KS − and was thus under control of the T7 promoter. A Cterminal deletion of the URE2 gene was constructed by digesting 
Yeast procedures
The Y190 strain (MATa ; GAL4∆ ; GAL80∆ ; ade2-101 ; his3-∆200 ; leu2-3,112 ; trp1-901 ; ura3-52 ; URA3 : : UAS-GAL1-lacZ ; LYS2 ::GAL1-HIS3 ; CYH R ) was used to test the different interactions. Transformation of yeast cells was carried out as previously described [17] . The co-transformations were performed as indicated in Table 1 .
The enzymic activities were determined as follows : yeast transformants were collected after a 4-day incubation directly from selective plates and harvested by centrifugation at 3000 g for 5 min at 4 mC. Cells were resuspended in 300 µl of ice-cold Z buffer (0.06 M Na
, and vortexed in presence of 150 µl of chilled glass beads (0.45 mm diameter), with two cycles of 1 min of blending and 1 min of cooling in ice. The extracts were then centrifuged at 12 000 g for 10 min at 4 mC and supernatants (crude extract) were collected. Supernatant (5 µl) was used to quantify the proteins by a bicinchoninic acid assay (Pierce, Rockford, IL, U.S.A.).
β-Galactosidase assays were performed as follows : 200 µl of crude extract was added to 800 µl of buffer Z containing the substrate O-nitrophenyl-β--galactopyranoside, 4 mg\ml. After 0, 10, 30 and 120 min of incubation at 37 mC, 200 µl of each reaction was simultaneously stopped by adding 800 µl of 1 M Na # CO $ . After measurement of the absorbance at 420 nm, β-galactosidase activity was calculated by linear regression. A β-galactosidase unit was defined as an A %#! unit\min of reaction per µg of protein of total extract. The final results are represented as percentage of the activation given by the complete URE2 ORF in the respective plasmids. 
In vitro transcription/translation procedures
Affinity-binding procedure
The ∆C (97-354)-(6iHis)-tagged Ure2p translation mixture (35 µl) was incubated with 20 µl of the full-length protein (equimolar amounts) and incubated for 1.5 h at 30 mC. In a control, 20 µl of the full-length Ure2p was incubated with 35 µl of the wheat germ extract.
After that, 55 µl of 2i concentrated Na-phosphate buffer (100 mM NaH # PO % \600 mM NaCl\20mM imidazole) was added, and the mixture was laid on a Ni-NTA (nickel nitriloacetic acid) Spin Column (Qiagen, Courtaboeuf, France). The column was equilibrated with 400 µl of a 50 mM NaH # PO % buffer, pH 4.8, containing 300 mM NaCl and 10 mM imidazole (Sigma, St. Louis, MO, U.S.A.). Centrifugations were performed for 3 min at 380 g. Each sample was applied to a column. Then the column was washed with 200 µl of a 50 mM NaH # PO % buffer, pH 4.8, containing 300 mM NaCl and 50 mM imidazole. Elution was performed in presence of 200 µl of a 50 mM NaH # PO % buffer, pH 4.8, containing 300 mM NaCl and 250 mM imidazole. Sample aliquots were mixed with 50 mM Tris\HCl electrophoresis sample buffer, pH 6.8, containing 4 % (w\v) SDS\2 % (v\v) β-mercaptoethanol\12 % (w\v) glycerol\0.01 % Serva Blue G, and immediately incubated at 80 mC for 10 min. The samples were analysed by PAGE according to [18] in a 16.5 % T, 6 % C gel, overlaid with a 4 % T, 3 % C stacking gel. Rainbow "%C-labelled methylated coloured proteins (Amersham) were used as molecular-mass markers. Gels were fixed, dried under vacuum and subjected to autoradiography using a Molecular Dynamics PhosphorImager and ImageQuant software.
RESULTS
Ure2p acts as an activator able to interact with itself
After a transformation of the yeast strain Y190 by pAS2-URE2 alone (the bait), the transformants were collected. These yeast cells express a chimaeric protein that contains the binding domain of GAL4p and Ure2p. The possible effects of Ure2p on the transcription machinery can then be measured by the activation of a specially designed reporter gene that carrys the binding site for the DNA binding partner. For the strain used in our study, the reporter gene was β-galactosidase. A qualitative test showed a strong activation, since a deep blue colour due to the β-galactosidase appeared after 10 min. This result could be due to a real transcriptional activation function for Ure2p and would make any screening procedure completely inefficient, due to the high background. When transformed with both pAS2-URE2 and pACT3-URE2 (the prey), the yeast cells produced a larger amount of β-galactosidase, as the same blue colour appeared after only 5 min. This result suggested that Ure2p interacting with itself could then increase the transcription of the reporter gene. To investigate this possibility we measured the level of β-galactosidase produced when the yeast cells were transformed with pAS2-URE2 and pACT3 or with pAS2-URE2 and pACT3-URE2. In this latter case, the β-galactosidase specific activity was two-fold higher than in the former case (results not shown). This higher amount of β-galactosidase in the cells transformed with both pAS2-URE2 and pACT3-URE2 compared with cells containing only Ure2p as bait indicated the existence of an interaction between Ure2p and itself.
A popular approach with the two-hybrid system uses the construction in pAS2 vector as bait in a screening procedure. Unfortunately, the basal level of transcription due to the original URE2 construction made a screening procedure with a yeast genomic bank hazardous. Moreover, the previous construction did not permit the characterization of interacting domains. We thus decided to test the transcriptional activation of a collection of baits corresponding to different deletions of Ure2p.
The catalytic domain of Ure2p corresponds to an activating domain
Ure2p contains two domains (see Figure 1) [19] . The first one, corresponding to the first 25 % of the protein, possesses the major ' prion ' properties. This part of the sequence is strictly required for the appearance of [URE3] and by itself is sufficient to induce it. It has been shown recently that this domain alone allows the maintenance of [URE3] [20] . The rest of the protein corresponds to the catalytic domain, which represses Gln3p in the presence of a rich nitrogen source [21, 22] . This domain retains all the properties of the full-length protein except the ability to present the so-called prion phenotype [URE3]. We made three N-terminal deletions of Ure2p that eliminate the first 63, 96 or 152 residues for the constructions ∆N (1-63), ∆N (1-96) and ∆N (1-152) respectively, and three C-terminal deletions that retain the first 96, 151 and 225 residues of Ure2p for the constructions ∆C (97-354), ∆C (152-354) and ∆C (226-354) respectively. These deletions, represented in Figure 1 , are all in frame with the binding domain of Gal4p.
When expressed alone, all the ∆C-Ure2p-Gal4p constructions exhibited a very low level of β-galactosidase activity. However, yeast cells transformed by the hybrid Ure2p-Gal4p or ∆N-Ure2p-Gal4p (see Table 1 , column 1) presented significant β-galactosidase activity. These results suggest a correlation between the catalytic domain of Ure2p and the transactivating activity detected in this study.
In order to determine if these deletions retained the ability to interact with Ure2p, we co-transformed yeast cells with each construction and with pACT3-URE2, and the level of β-galactosidase activity thus obtained was measured.
The prion domain interacts with Ure2p
Each deletion was tested for its ability to activate the transcription of the β-galactosidase reporter gene when expressed in yeast cells containing Ure2p in frame with the binding domain, and also in yeast cells containing only the binding domain. The strain Y190 was co-transformed by the different combinations of plasmids. After selection of the double-transformed yeast cells, they were broken and the amount of β-galactosidase was determined. The results obtained (Table 1 , columns 1 and 2) are expressed as a percentage of the activity measured in yeast transformed by pAS2-URE2 and pACT3-URE2.
In the same conditions, ∆N (1-152) and ∆N (1-96) displayed no significant differences in transactivating activities when expressed with Ure2p in frame with the activating domain or with the activating domain alone (88 versus 61, and 13 versus 14, respectively ; these are arbitrary units, see Table 1 ).
On the other hand, the presence of Ure2p in frame with the binding domain dramatically increased the amount of β-galactosidase measured for the three ∆C deletions. The longest deletion, ∆C (97-354), which retained only the first 96 amino acids of Ure2p, exhibited a three-fold higher β-galactosidase activity in the presence of Ure2p in frame with the activating domain of Gal4p (22 versus 7.9 ). This increase clearly indicates an interaction between the first third of the protein that contains all the prion domain and Ure2p. Interestingly, ∆N (1-63) also exhibited a higher β-galactosidase activity when expressed with Ure2p fused in frame with the activating domain (118 versus 40).
In order to confirm the result observed with the two-hybrid system, we decided to test the putative interaction by affinity binding of in itro translated proteins.
Interacting domains can be monitored by affinity binding
Full-length untagged Ure2p and truncated ∆C (97-354)-(6iHis)-tagged Ure2p were expressed using the wheat germ extract cell-free translation system. Equimolar amounts were mixed, and this mix was loaded on to a Ni-NTA column (see Figure 2) . As a control, the full-length untagged protein was loaded on to a similar column in the same conditions. In both cases, the columns were washed with a 50 mM imidazole buffer and eluted with a 250 mM imidazole buffer. In the control, Ure2p was not detectable in the eluted fraction (Figure 2 , Control, lane E). In contrast, a significant amount of the untagged Ure2p was co-eluted with the truncated ∆C (97-354)-(6iHis)-tagged Ure2p (Figure 2 , Mix, lane E). The presence of the fulllength Ure2p in this fraction is evidently due to an interaction between both polypeptides.
Figure 2 Autoradiogram of SDS gel electrophoresis of the full-length untagged Ure2p mRNA (A) and ∆C (97-354)-(6iHis)-tagged Ure2p mRNA (B) cellfree translation products
Mix : both full-length Ure2p and ∆C (97-354)-Ure2p were equimolarly mixed together. BC, mix before purification ; FT, flow through the column ; W, wash with 50 mM imidazole ; E, elution with 250 mM imidazole. The molecular ratio A/B in lane E was 1/9. Control : the full-length Ure2p alone was used as control. Note : the ∆C (97-354)-Ure2p had an apparent molecular mass higher than that expected from its sequence (about 8 kDa), because of its unusual amino acid composition. Similar migration abnormalities have been described for another protein [30] . The autoradiogram was digitally processed using a Molecular Dynamics PhosphorImager and ImageQuant software.
Figure 3 The two hypotheses of interacting domains of Ure2p
Hypothesis 1 : there is one interacting domain (grey box), common to the ∆C (97-354) and ∆N (1-63) truncated proteins, as these constructions are both able to interact with Ure2p in the two-hybrid system. Hypothesis 2 : Ure2p contains two interacting domains (grey boxes), α and β.
This result confirms the interaction previously detected between the prion-forming domain (PFD) of Ure2p and Ure2p. This interaction could be due either to a unique domain located in the PFD or alternatively to the presence of two different domains. To distinguish between these two hypotheses we decided to perform further two-hybrid experiments.
Ure2p contains at least two interacting domains
∆N (1-63) and ∆C (97-354), which both interact with Ure2p, share a common part of URE2 that could be considered as the sole interacting domain of Ure2p (see Figure 3, hypothesis 1) . Alternatively, one can postulate two interacting domains (see Figure 3 , hypothesis 2). The first one (α domain) would be located in the first third of Ure2p and would be present in ∆C (97-354), and the second one (β domain) located in the rest of the molecule, thus present in ∆N (1-63).
Both ∆N (1-152) and ∆N (1-96), which include the putative β domain but not the α domain, do not interact with Ure2p. This result argues against the second hypothesis but may also be due to a particular folding of chimaerical proteins coded by pAS2-∆N (1-152) and pAS2-∆N (1-96), which could mask this interacting domain, explaining the absence of significant interaction of Ure2p with these constructions. To address this question, we decided to test the truncated ∆N (1-152) construct not as bait, but as prey. Although this construction expressed the same primary sequence of URE2, the fusion with the activating domain of Gal4p rather than the binding domain could change the capacity of this truncated protein to interact with Ure2p.
The yeast cells were thus transformed with all the baits in combination with ∆N (1-152) as the prey. The β-galactosidasespecific activity was measured as previously described. The result is presented in Table 1 , column 3. This deletion interacts with Ure2p when the full-length protein is used as the bait (121 versus 63). As ∆N (1-152) does not share the putative interacting domain common to ∆C (152-354) and ∆C (97-354), we therefore conclude that at least two different interacting domains exist (see Figure 3 , hypothesis 2). This interaction demonstrates the presence of the β domain in the ∆N (1-152) construction.
In order to analyse the relationship between α and β domains, we used ∆C (152-354) as the prey (Table 1, ∆N (1-152) . In addition, we observed a strong interaction between the ∆C (152-354) constructions used both as bait and prey, as the β-galactosidase activity increased 13-fold compared with the control (26 versus 2). In conclusion, these experiments show that the α domain of the molecule, expressed in the ∆C (152-354) construction is able to interact with itself and with the β domain.
DISCUSSION
The two-hybrid approach is a popular way to increase our knowledge of a protein by identifying cellular partners. In some cases, it can help to assign a function to a gene [23] . This technique can also be used to further define previously reported interactions [24, 25] . As the measurement of the interaction implies several factors, such as the number of copies of the plasmid per cell, efficiency of translation of the hybrid proteins, nuclear targeting of the baits and preys and finally the interaction of the two hybrids, it is not possible to strictly correlate the β-galactosidase activity with the affinity of the interaction in i o. Moreover, the folding of the protein can be affected by its fusion to a part of Gal4p and therefore can lead to a tertiary structure completely different from the expected one. However, many studies have demonstrated the efficiency of this technique, either to characterize the interacting domains of a protein or to identify cellular partners. In this study, we demonstrate on the basis of this technique that Ure2p is able to interact with itself. This interaction involves two domains : the α domain, which is located between amino acids 1 and 63, and the β domain, which is located between amino acids 152 and 354. The α domain is able to interact with itself and with the β domain.
We have also demonstrated that the in itro-expressed Nterminal part of Ure2p, comprising residues 1-96, is able to bind Ure2p. However, we observed in this case that the fulllength Ure2p was not eluted in equimolar amounts with the tagged truncated Ure2p (see Figure 2 ). This fact suggests that this interaction is weak and\or unstable under the conditions of the experiment, which are far remote from the in i o ones.
Ure2p and Sup35p form the family of yeast prions [7, 26] . It has been shown that Sup35p can form fibres and this polymerization could explain the conversion of the cellular protein [27] [28] [29] . No such molecular data are yet available for Ure2p. This protein has not yet been purified either from yeast or from a heterologous system permitting a strong over-production, such as E. coli. The molecular mechanism explaining the formation and propagation of [URE3] thus remains largely unknown. Genetic data strongly suggest that the protein contains two domains acting independently in the yeast prion propagation [6, 19, 20] . The C-terminal domain of Ure2p (residues 66-354) fails to induce [URE3] formation and even decreases the rate of [URE3] appearance [19] . This domain can not propagate by itself the prion introduced by cytoduction [20] . In contrast, the Nterminal domain (called the PFD) is able to increase the rate of [URE3] appearance and may maintain the prion introduced by cytoduction, but less efficiently than the whole protein. Our data show that the first half of the protein (including the prion domain) can interact with itself but also with the second half Received 10 September 1998/6 November 1998 ; accepted 11 December 1998 (representing part of the catalytic domain). These interactions may reflect two kinds of events : one corresponding to the regular function of Ure2p and the other allowing the formation of an altered Ure2p, giving rise to the [URE3] phenotype. Our results are in agreement with the model of prion propagation described by Masison and co-authors [20] , who proposed an interaction between the N-terminal prion-inducing domain and the Cterminal nitrogen-regulation domain of Ure2p. We now need precise biochemical data to achieve functional studies of this protein in regard to prion propagation but also to the cellular function of this nitrogen regulator. For this purpose, the hunting of cellular partners with our bait may be very rewarding.
